News
Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...
Radiopharmaceutical biotech Actithera today announced the close of an oversubscribed $75.5 million Series A financing round.
Donald Trump has escalated his warnings to the pharmaceutical industry with a pledge to introduce import tariffs as high as ...
San Francisco, USA-based biotech Centivax, which is developing durable, universal vaccines, today announced the close of a ...
Prior to joining Crescent, Dr Pinkas was CSO at Pyxis Oncology (Nasdaq: PYXS), where he established the preclinical research ...
Debra Barker has been named chief medical officer (CMO) at Centauri Therapeutics, a UK immunotherapy company with a ...
Switzerland-based MetP Pharma, pioneer in nose-to-brain drug delivery for nearly two decades, announced new data highlighting ...
Diagonal Therapeutics, a US biotech focused on correcting dysregulated signaling with clustering antibodies that address the ...
The US subsidiary of South Korea-based Celltrion today announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) ...
US biotech Cogent Biosciences closed Monday’s trading 23% higher, following the company’s announcement of positive top-line ...
Having appointed Renée Aguiar-Lucander as its chief executive in April and Maria Törnsén as chief operating officer a month ...
Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results